AMGN

What one share of Amgen holds

Biological Products, (No Diagnostic Substances)

Amgen Inc. (including its subsidiaries, referred to as “Amgen,” “the Company,” “we,” “our” or “us”) discovers, develops, manufactures and delivers innovative medicines to fight some of the world’s toughest diseases. We focus on areas of high unmet medical need and leverage our expertise to strive for solutions that dramatically improve people’s lives, while also reducing the social and economic burden of disease.

Amgen’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.

Per-share figures
Sales$70.09
Profit$16.09
Capex (buildings and equipment)$4.24
Free cash flow$18.72
Dividends$9.80
Cash and investments$25.88
Debt$106.00
Book value$21.62

Per share by fiscal year

YearSalesProfitCapexFree cashDividendsBook value
2007$13.15$2.74$1.13$3.68—$16.57
2008$13.96$3.77$0.63$4.95—$19.95
2009$14.34$4.51$0.52$5.69—$22.78
2010$15.60$4.79$0.60$5.40—$25.69
2011$17.09$4.04$0.62$4.99—$23.92
2012$21.94$5.52$0.88$6.60—$25.20
2013$24.41$6.64$0.91$7.32—$29.28
2014$26.06$6.70$0.93$10.69—$33.90
2015$28.28$9.06$0.78$11.93—$37.25
2016$30.49$10.24$0.98$12.75$4.15$40.47
2017$31.09$2.69$0.90$14.30$4.77$34.95
2018$35.71$12.62$1.11$15.88$5.41$19.85
2019$38.36$12.88$1.01$14.01$5.95$16.36
2020$43.09$12.31$1.03$16.76$6.56$16.27
2021$45.34$10.28$1.54$14.63$7.22$12.00
2022$48.66$12.11$1.73$16.24$7.95$6.86
2023$52.40$12.49$2.07$13.68$8.64$11.64
2024$61.78$7.56$2.03$19.21$9.13$10.95
2025$67.81$14.23$3.43$14.94$9.66$16.07